Genetic Heterogeneity Underlying Phenotypes with Early-Onset Cerebellar Atrophy.
Autores de CIPF
Participantes ajenos a CIPF
- Argente-Escrig H
- Marco-Marín C
- Lozano MA
- Gorría-Redondo N
- Martí-Carrera I
- Miranda C
- Vázquez-López M
- García-Pérez A
- Marco-Hernández AV
- Tomás-Vila M
- Aguilera-Albesa S
Grupos de Investigación
Abstract
Cerebellar atrophy (CA) is a frequent neuroimaging finding in paediatric neurology, usually associated with cerebellar ataxia. The list of genes involved in hereditary forms of CA is continuously growing and reveals its genetic complexity. We investigated ten cases with early-onset cerebellar involvement with and without ataxia by exome sequencing or by a targeted panel with 363 genes involved in ataxia or spastic paraplegia. Novel variants were investigated by in silico or experimental approaches. Seven probands carry causative variants in well-known genes associated with CA or cerebellar hypoplasia: SETX, CACNA1G, CACNA1A, CLN6 , CPLANE1 , and TBCD . The remaining three cases deserve special attention; they harbour variants in MAST1, PI4KA and CLK2 genes. MAST1 is responsible for an ultrarare condition characterised by global developmental delay and cognitive decline; our index case added ataxia to the list of concomitant associated symptoms. PIK4A is mainly related to hypomyelinating leukodystrophy; our proband presented with pure spastic paraplegia and normal intellectual capacity. Finally, in a patient who suffers from mild ataxia with oculomotor apraxia, the de novo novel CLK2 c.1120T>C variant was found. The protein expression of the mutated protein was reduced, which may indicate instability that would affect its kinase activity.
Datos de la publicación
- ISSN/ISSNe:
- 1422-0067, 1422-0067
- Tipo:
- Article
- Páginas:
- -
- PubMed:
- 38003592
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES MDPI
Citas Recibidas en Web of Science: 5
Documentos
- No hay documentos
Filiaciones
Keywords
- ataxia, cerebellar atrophy, exome sequencing, gene panel, neuroimaging, rare disease
Proyectos asociados
PID10470. No se ingresará dinero en el CIPF. La ayuda consiste en un estudio genómico (long & read-sequencing) para 25 muestras.
Investigador Principal: CARMEN ESPINÓS ARMERO
EASI- Genomics . 2020
Estudios clínicos, bases genéticas y biomarcadores pronóstico en enfermedades raras neurodegenerativas
Investigador Principal: CARMEN ESPINÓS ARMERO
INSTITUTO DE SALUD CARLOS III . 2022
Microbiota aplicada para la salud, coordinado por Ana ramírez del centro Instituto Madrileño de Estudios Avanzados (IMDEA-Alimentación). La Dra. Carmen Espinós Armero y el Dr. Alfonso Benítez participan en calidad de componentes del equipo
MINISTERIO DE CIENCIA, INNOVACION Y UNIVERSIDADES . 2023
Simposio internacional sobre la enfermedad de Wilson
Investigador Principal: CARMEN ESPINÓS ARMERO
GENERALITAT VALENCIANA . 2023
Nuevos biomarcadores y tratamientos para la epilepsia infantil
Investigador Principal: CARMEN ESPINÓS ARMERO
GENERALITAT VALENCIANA . 2023